Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1124 results for "ranbaxy"

Our objective is to integrate Ranbaxy at the earliest: Dilip Shanghvi
India Infoline

Our objective is to integrate Ranbaxy at the earliest: Dilip S...

Shanghvi said that the primary objective of the company is to conclude Ranbaxy integration as early as possible so as to drive away attached uncertainties. Dilip Shanghvi, founder and managing director of Sun Pharmaceuticals talked about the company's ... India Infoline, 8 hours ago
[x]  

214 images for ranbaxy

Med India, 1 day ago
Money Today, 3 days ago
Money Today, 4 days ago
Money Today, 4 days ago
Business Today India, 4 days ago
Deccan Chronicle, 4 days ago
Money Today, 3 days ago
India TV, 5 days ago
Times of India, 5 days ago
NDTV Profit, 4 days ago
The Telegraph

Sun Pharma to delist Ranbaxy on $4b merger end

Sun Pharmaceutical Wednesday said Ranbaxy will be delisted from the Indian bourses following the completion of their USD 4 billion merger. "Following the closure of this transaction, Ranbaxy will be delisted from the Indian Stock Exchanges.
 The Echo Of India4 days ago Sun prescription for growth  The Telegraph4 days ago Sun Pharma to focus on productivity, synergies after Ranbaxy merger  Financial Express4 days ago Ranbaxy merges with Sun  Asian Age4 days ago
[x]  
Nikkei Asian Review

Ranbaxy fades into sunset

Sun Pharma to focus on integration, open to more acquisitions
 DNA3 days ago India's Sun Pharmaceutical Closes USD 4bn Merger with Ranbaxy  Bloomberg4 days ago Sun Pharma wraps up Ranbaxy deal  Nikkei Asian Review4 days ago India's Sun Pharma open to large acquisitions post Ranbaxy deal  Reuters UK4 days ago
[x]  
Livemint.com

Sun Pharma brings to closure Ranbaxy merger

India's largest pharma company Sun Pharmaceutical Industries on Wednesday announced the closure of its merger with Ranbaxy Laboratories saying the integration will deliver synergies worth $250 million (over Rs.1,500 crore) in three years."The merger has ...
 Prokerala4 days ago Sun Pharma, Ranbaxy edge higher  Capital Market4 days ago Ranbaxy Laboratories updates on scheme of arrangement  Capital Market5 days ago Emcure to buy divested assets of Sun Pharma and Ranbaxy  Livemint.com6 days ago
[x]  

India's Sun Pharma completes $3.2bn merger deal with Ranbaxy

India-based Sun Pharmaceutical Industries has completed the merger with Ranbaxy, as part of a $3.2bn deal. Sun has started integration of the acquired business that allows the firm to become the fifth largest specialty generic pharmaceutical ...
 Pharmaceutical Technology3 days ago Sun Pharma, Ranbaxy rise 2% post completion of merger deal  Money Control4 days ago Sun Pharma finally completes Ranbaxy acquisition  Pharma Letter4 days ago
Money Today

Ranbaxy stock to stop trading on exchanges from April 6

Sun Pharma would be delisting Ranbaxy from the exchanges. It has consummated the merger of Ranbaxy following receipt of requisite approvals. In sep
 Money Today4 days ago Ranbaxy: April 1 set as last day for trading  Hindu Business Line4 days ago Ranbaxy Shares to Stop Trading on Exchanges From April 6  New Indian Express4 days ago Ranbaxy Shares to Stop Trading on Bourses From April 6  NDTV Profit4 days ago
[x]  

Sell Ranbaxy with a target of Rs 785: Sandeep Wagle

Comments are moderated and will be allowed if they are about the topic and not abusive. Characters remaining ( 1500 ) To post this comment you must Log In/Connect with: Indiatimes Network or Fill in your details: Will be displayed Will not be displayed Will ...
 Economic Times2 days ago Buy Ranbaxy Labs with a target of Rs 814: Sandeep Wagle.  Economic Times1 week ago Buy Ranbaxy with a target of Rs 850: Prakash Gaba  Economic Times2 weeks ago Buy Ranbaxy with a target of Rs 755: Sandeep Wagle  Economic Times1 month ago
Business Standard

BSE to discontinue trading in Ranbaxy from April 6

scrip from S BSE 100, S BSE 200, S BSE 500, S BSE Healthcare and S BSE Carbonex indices from April 6. After Ranbaxy's merger with Sun Pharma, the scrip will be discountinued from trading on the bourses, while Ranbaxy shareholders will receive 0.8 share of Sun ...
 Business Standard2 days ago Pharma shares gain; BSE Healthcare index up nearly 200 points  Business Standard4 weeks ago

News Flash: Havas Media wins digital mandate of Caterpillar India

This is the second digital win of the year after Ranbaxy and further strengthens Havas Media's presence in Bangalore BestMediaInfo Bureau | Delhi | March 26, 2015 Havas Media Group India has started 2015 on a very positive note. They have won ...
 Best Media Info3 days ago Havas Media bags digital duties of Ranbaxy's Consumer Healthcare brands  Afaqs1 month ago Havas wins digital mandate of Caterpillar India  Afaqs3 days ago Havas Media Group India wins digital mandate of Caterpillar India  Indian Television3 days ago
Money Control

Here are top 10 stocks to focus on March 24

Here are top 10 stocks to focus on March 24 – HDFC, Wockhardt, Geometric, GMR Infra, Sun Pharma, Ranbaxy, Hero Moto, JSPL, Adani Power and Aarti Drugs.
 Money Control5 days ago Top buzzing midcap stocks to trade on March 23  Money Control6 days ago Stocks in news: Bharti, Idea, Titan, LT, Ranbaxy, Hindalco  Money Control2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less